Why the J&J vaccine is SA’s best hope
Johnson & Johnson is expected to release its vaccine trial data later this week. If successful, it could be a promising development for SA
27 January 2021 - 08:30
A year into the coronavirus pandemic, elderly people most at risk of death from Covid-19, still stand in long, crowded queues in SA to access their social grants.
If the government is struggling to ensure monthly grant distribution is safe and automated, imagine the logistical difficulty of giving two doses of a vaccine, weeks apart, to millions of people in far-flung areas. To smooth the path of vaccinating 40-million people — the threshold government is aiming for — it would seem logical to try use a vaccine that is administered just once...
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now